Angela I. Schriek

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans.

Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans.

Journal: PLoS pathogens
Published: January 19, 2025

Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions.

Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions.

Journal: Antiviral research
Published: July 12, 2024

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Journal: iScience
Published: April 29, 2024

Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.

Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.

Journal: PLoS pathogens
Published: April 22, 2024

Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism.

Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism.

Journal: Biochemical pharmacology
Published: April 10, 2024

Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacy.

Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacy.

Journal: Plant biotechnology journal
Published: April 05, 2024

Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.

Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.

Journal: PLoS pathogens
Published: March 21, 2024

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing.

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing.

Journal: Communications biology
Published: January 15, 2024

Next-generation bNAbs for HIV-1 cure strategies.

Next-generation bNAbs for HIV-1 cure strategies.

Journal: Antiviral research
Published: October 10, 2023

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses.

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses.

Journal: iScience
Published: November 17, 2022

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.

Journal: Frontiers in immunology
Published: November 07, 2022

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.

Journal: Cell host & microbe
Published: April 08, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026